Publications in collaboration with researchers from Homerton University Hospital (18)

2022

  1. STATIN trial: predictive performance of competing-risks model in screening for pre-eclampsia at 35–37 weeks' gestation

    Ultrasound in Obstetrics and Gynecology, Vol. 59, Núm. 1, pp. 69-75

2021

  1. Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial

    American Journal of Obstetrics and Gynecology, Vol. 224, Núm. 1, pp. 86.e1-86.e19

  2. Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

    BJS Open

  3. Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score

    British Journal of Surgery, Vol. 19, Núm. 4

  4. Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia

    Circulation, Vol. 144, Núm. 9, pp. 670-679

  5. Prediction of pre-eclampsia in twin pregnancy by maternal factors and biomarkers at 11–13 weeks' gestation: data from EVENTS trial

    Ultrasound in Obstetrics and Gynecology, Vol. 57, Núm. 2, pp. 257-265

2018

  1. ASPRE Trial: Incidence of Preterm Preeclampsia in Patients Fulfilling ACOG and NICE Criteria According to Risk by FMF Algorithm

    Obstetrical and Gynecological Survey, Vol. 73, Núm. 11, pp. 623-625

  2. ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm

    Ultrasound in Obstetrics and Gynecology, Vol. 51, Núm. 6, pp. 738-742

  3. Aspirin Versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia

    Obstetrical and Gynecological Survey

  4. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit

    American Journal of Obstetrics and Gynecology, Vol. 218, Núm. 6, pp. 612.e1-612.e6

  5. Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE

    Ultrasound in Obstetrics and Gynecology, Vol. 52, Núm. 1, pp. 52-59

  6. Screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation

    Ultrasound in Obstetrics and Gynecology, Vol. 52, Núm. 2, pp. 186-195

2017

  1. ASPRE trial: performance of screening for preterm pre-eclampsia

    Ultrasound in Obstetrics and Gynecology, Vol. 50, Núm. 4, pp. 492-495

  2. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation

    Ultrasound in Obstetrics and Gynecology, Vol. 49, Núm. 6, pp. 751-755

  3. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history

    American Journal of Obstetrics and Gynecology, Vol. 217, Núm. 5, pp. 585.e1-585.e5

  4. Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia

    American Journal of Obstetrics and Gynecology, Vol. 217, Núm. 6, pp. 685.e1-685.e5

  5. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia

    New England Journal of Medicine, Vol. 377, Núm. 7, pp. 613-622

  6. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations

    Ultrasound in Obstetrics and Gynecology, Vol. 49, Núm. 6, pp. 756-760